Skip to main content
Kyowa Kirin Co.,Ltd. logo

Kyowa Kirin Co.,Ltd. — Investor Relations & Filings

Ticker · 4151 ISIN · JP3256000005 LEI · 529900TBXKVTQGYA3582 T Manufacturing
Open in API
Filings indexed 75 across all filing types
Latest filing 2026-05-07 Regulatory Filings
Country JP Japan
Listing T 4151

About Kyowa Kirin Co.,Ltd.

https://www.kyowakirin.com/index.html

Kyowa Kirin is a global specialty pharmaceutical company engaged in the research, development, manufacturing, and commercialization of innovative medicines. Leveraging advanced biotechnology and expertise in antibody engineering, the company is dedicated to addressing unmet medical needs. Its primary focus is on creating novel treatments in therapeutic areas such as oncology, nephrology, and immunology. Kyowa Kirin is committed to discovering and delivering drugs for complex and rare diseases, aiming to improve the health and well-being of patients worldwide.

Recent filings

Filing Released Lang Actions
決算短信 補足資料 －2026年12月期 第1四半期－
Regulatory Filings
2026-05-07 Japanese
2026年12月期 第1四半期決算短信〔IFRS〕（連結）
Regulatory Filings
2026-05-07 Japanese
訂正有価証券届出書（参照方式）
Share Issue/Capital Change Classification · 85% confidence The document is a “訂正有価証券届出書” (Corrected Securities Registration Statement) under Japanese Financial Instruments and Exchange Act, detailing the terms, number of shares, allotment, and conditions of a share issuance (self-stock disposition under share-based compensation schemes). It is not an AGM material or earnings release, but a capital market transaction concerning issuance of new equity. This clearly falls under “Share Issue/Capital Change” (SHA).
2026-03-23 Japanese
有価証券届出書（参照方式）
Share Issue/Capital Change Classification · 95% confidence The document is a '有価証券届出書' (Securities Registration Statement) filed with the Kanto Local Finance Bureau by Kyowa Kirin Co., Ltd. It details the issuance of new shares as part of a restricted stock compensation plan and performance-linked stock compensation plan for directors and executives. In the context of Japanese financial filings, this is a regulatory filing related to capital changes and share issuance. Since it specifically details the issuance of shares (capital change) rather than just an announcement of a report, it falls under the 'Share Issue/Capital Change' category.
2026-03-19 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act, Article 24-4-2, Paragraph 1. It serves as an officer certification confirming the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'Certification Rule', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type, as they do not contain the actual financial statements themselves. FY 2025
2026-03-10 Japanese
有価証券報告書－第103期(2025/01/01－2025/12/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K. It contains the standard cover page for such filings, including the company name (Kyowa Kirin Co., Ltd.), the fiscal year (2025), and the regulatory submission details to the Kanto Local Finance Bureau. It is a comprehensive annual financial disclosure document. FY 2025
2026-03-10 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.